Petter Bjornstad, M.D.

Citeras av

	Alla	Sedan 2019
Citat	6661	5480
h-index	43	37
i10-index	123	116

1300

650

325

975

2014201520162017201820192020202120222023202455 137 200 244 466 606 830 1032 1229 1298 458

Offentlig åtkomst

Visa alla

148 artiklar

4 artiklar

tillgänglig

inte tillgänglig

Enligt krav från finansiärer

Medförfattare

David Z. CherneyProfessor of Medicine, University of TorontoVerifierad e-postadress på uhn.ca
Richard J JohnsonUniv of WA, Baylor, Univ of Florida, Univ of COVerifierad e-postadress på ucdenver.edu
Laura PyleUniversity of ColoradoVerifierad e-postadress på ucdenver.edu
Miguel A. LanaspaUniversity of Colorado Anschutz Medical Campus. Univ.ZaragozaVerifierad e-postadress på ucdenver.edu
Julie A. Lovshin, MD, PhD, FRCPCEndocrinology and Metabolism, University of TorontoVerifierad e-postadress på lunenfeld.ca
Carlos Roncal-JimenezUniversity of ColoradoVerifierad e-postadress på ucdenver.edu
Robert G NelsonSenior Investigator, National Institute of Diabetes and Digestive and Kidney DiseasesVerifierad e-postadress på nih.gov
Bruce A. PerkinsProfessor of Medicine, Endocrinology and Metabolism, University of TorontoVerifierad e-postadress på sinaihealthsystem.ca
jane reuschProfessor of Medicien, Universtiy of Colorado and Denver VAMCVerifierad e-postadress på ucdenver.edu
Masanari KuwabaraJichi Medical UniversityVerifierad e-postadress på ucdenver.edu
Michal SchaferUniversity of UtahVerifierad e-postadress på hsc.utah.edu
Mohammed A. Malik FarooqiResident Physician, Critical Care, McMaster UniversityVerifierad e-postadress på medportal.ca
Heather N. ReichUniversity of TorontoVerifierad e-postadress på uhn.ca
Jacob A. UdellUniversity of TorontoVerifierad e-postadress på utoronto.ca
Christopher RivardUniversity of Colorado DenverVerifierad e-postadress på ucdenver.edu
Alex J. BarkerAssociate ProfessorVerifierad e-postadress på ucdenver.edu
Kendall HunterAssociate Professor of Bioengineering, University of Colorado Anschutz Medical CampusVerifierad e-postadress på ucdenver.edu
Judith G RegensteinerUniversity of Colorado - DenverVerifierad e-postadress på ucdenver.edu
Paul YipSunnybrook Hospital, University of TorontoVerifierad e-postadress på utoronto.ca
R. Brett McQueenUniversity of Colorado Skaggs School of Pharmacy and Pharmaceutical SciencesVerifierad e-postadress på ucdenver.edu

Följ

Petter Bjornstad, M.D.

University of Colorado School of Medicine / Children's Hospital Colorado

Verifierad e-postadress på childrenscolorado.org

Type 1 Diabetes Microvascular complications Macrovascular complications Epidemiology


Titel Sortera efter citat Sortera efter år Sortera efter titel	Citeras av Citeras av	År
Age-related consequences of childhood obesity MM Kelsey, A Zaepfel, P Bjornstad, KJ Nadeau Gerontology 60 (3), 222-228, 2014	641	2014
Sodium glucose cotransporter-2 inhibition in heart failure: potential mechanisms, clinical applications, and summary of clinical trials Y Lytvyn, P Bjornstad, JA Udell, JA Lovshin, DZI Cherney Circulation 136 (17), 1643-1658, 2017	486	2017
Long-term complications in youth-onset type 2 diabetes TODAY Study Group New England Journal of Medicine 385 (5), 416-426, 2021	268	2021
Uric acid is a strong risk marker for developing hypertension from prehypertension: a 5-year Japanese cohort study M Kuwabara, I Hisatome, K Niwa, S Hara, CA Roncal-Jimenez, ... Hypertension 71 (1), 78-86, 2018	237	2018
Asymptomatic hyperuricemia without comorbidities predicts cardiometabolic diseases: five-year Japanese cohort study M Kuwabara, K Niwa, I Hisatome, T Nakagawa, CA Roncal-Jimenez, ... Hypertension 69 (6), 1036-1044, 2017	212	2017
Pathogenesis of lipid disorders in insulin resistance: a brief review P Bjornstad, RH Eckel Current diabetes reports 18, 1-8, 2018	148	2018
Uric acid and hypertension: an update with recommendations LG Sanchez-Lozada, B Rodriguez-Iturbe, EE Kelley, T Nakagawa, ... American journal of hypertension 33 (7), 583-594, 2020	141	2020
Early diabetic nephropathy in type 1 diabetes: new insights P Bjornstad, D Cherney, DM Maahs Current Opinion in Endocrinology, Diabetes and Obesity 21 (4), 279-286, 2014	141	2014
The role of renal hypoxia in the pathogenesis of diabetic kidney disease: a promising target for newer renoprotective agents including SGLT2 inhibitors? AC Hesp, JA Schaub, PV Prasad, V Vallon, GD Laverman, P Bjornstad, ... Kidney international 98 (3), 579-589, 2020	135	2020
Asymptomatic hyperuricaemia: a silent activator of the innate immune system LAB Joosten, TO Crişan, P Bjornstad, RJ Johnson Nature Reviews Rheumatology 16 (2), 75-86, 2020	135	2020
Fructose and uric acid in diabetic nephropathy P Bjornstad, MA Lanaspa, T Ishimoto, T Kosugi, S Kume, D Jalal, ... Diabetologia 58, 1993-2002, 2015	126	2015
Metformin improves insulin sensitivity and vascular health in youth with type 1 diabetes mellitus: randomized controlled trial P Bjornstad, M Schäfer, U Truong, M Cree-Green, L Pyle, A Baumgartner, ... Circulation 138 (25), 2895-2907, 2018	112	2018
The new biology of diabetic kidney disease—mechanisms and therapeutic implications Y Lytvyn, P Bjornstad, DH van Raalte, HL Heerspink, DZI Cherney Endocrine reviews 41 (2), 202-231, 2020	108	2020
Rapid GFR decline is associated with renal hyperfiltration and impaired GFR in adults with Type 1 diabetes P Bjornstad, DZ Cherney, JK Snell-Bergeon, L Pyle, M Rewers, ... Nephrology Dialysis Transplantation 30 (10), 1706-1711, 2015	98	2015
Dapagliflozin in focal segmental glomerulosclerosis: a combined human-rodent pilot study H Rajasekeran, HN Reich, MA Hladunewich, D Cattran, JA Lovshin, ... American Journal of Physiology-Renal Physiology, 2018	88	2018
Elevated serum uric acid is associated with greater risk for hypertension and diabetic kidney diseases in obese adolescents with type 2 diabetes: an observational analysis from … P Bjornstad, L Laffel, J Lynch, L El Ghormli, RS Weinstock, SE Tollefsen, ... Diabetes Care 42 (6), 1120-1128, 2019	87	2019
Elevated serum uric acid level predicts rapid decline in kidney function M Kuwabara, P Bjornstad, I Hisatome, K Niwa, CA Roncal-Jimenez, ... American journal of nephrology 45 (4), 330-337, 2017	85	2017
Macrovascular disease and risk factors in youth with type 1 diabetes: time to be more attentive to treatment? P Bjornstad, KC Donaghue, DM Maahs The lancet diabetes & endocrinology 6 (10), 809-820, 2018	84	2018
Increased serum sodium and serum osmolarity are independent risk factors for developing chronic kidney disease; 5 year cohort study M Kuwabara, I Hisatome, CA Roncal-Jimenez, K Niwa, ... PLoS One 12 (1), e0169137, 2017	80	2017
Early diabetic nephropathy: a complication of reduced insulin sensitivity in type 1 diabetes P Bjornstad, JK Snell-Bergeon, M Rewers, D Jalal, MB Chonchol, ... Diabetes care 36 (11), 3678-3683, 2013	76	2013

Systemet kan inte utföra åtgärden just nu. Försök igen senare.

Artiklar 1–20

Citat per år

Dubblettcitat

Sammanfogade citat

Lägg till medförfattareMedförfattare

Följ

Citeras av

Medförfattare